DAMIANI, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 5.389
NA - Nord America 5.237
EU - Europa 4.943
SA - Sud America 465
AF - Africa 457
OC - Oceania 277
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.773
Nazione #
US - Stati Uniti d'America 5.030
CN - Cina 1.951
SG - Singapore 1.137
GB - Regno Unito 1.092
IT - Italia 981
DE - Germania 726
RU - Federazione Russa 453
IN - India 434
BR - Brasile 357
IE - Irlanda 333
ID - Indonesia 328
FR - Francia 285
SE - Svezia 254
AU - Australia 244
HK - Hong Kong 203
ET - Etiopia 200
JP - Giappone 200
TW - Taiwan 153
VN - Vietnam 148
CA - Canada 144
ES - Italia 136
KR - Corea 136
NL - Olanda 129
IR - Iran 123
AT - Austria 90
FI - Finlandia 89
TH - Thailandia 86
TR - Turchia 80
BD - Bangladesh 68
DK - Danimarca 63
ZA - Sudafrica 60
NG - Nigeria 58
CH - Svizzera 43
MX - Messico 43
PK - Pakistan 43
EG - Egitto 41
MY - Malesia 38
PH - Filippine 37
BE - Belgio 35
NP - Nepal 35
CL - Cile 33
IL - Israele 33
NZ - Nuova Zelanda 33
PL - Polonia 33
IQ - Iraq 31
AE - Emirati Arabi Uniti 30
UA - Ucraina 28
NO - Norvegia 27
CO - Colombia 24
RO - Romania 24
GR - Grecia 22
AR - Argentina 20
PT - Portogallo 19
RS - Serbia 18
SA - Arabia Saudita 18
KE - Kenya 15
PE - Perù 15
TN - Tunisia 13
GH - Ghana 12
CU - Cuba 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 9
LB - Libano 9
SI - Slovenia 9
DZ - Algeria 8
MA - Marocco 8
KG - Kirghizistan 7
VE - Venezuela 7
HU - Ungheria 6
LK - Sri Lanka 6
MM - Myanmar 6
SC - Seychelles 6
SL - Sierra Leone 6
UG - Uganda 6
BF - Burkina Faso 5
BY - Bielorussia 5
EC - Ecuador 5
JO - Giordania 5
LV - Lettonia 5
KZ - Kazakistan 4
MD - Moldavia 4
MZ - Mozambico 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TZ - Tanzania 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BO - Bolivia 3
EU - Europa 3
GE - Georgia 3
IS - Islanda 3
KH - Cambogia 3
KN - Saint Kitts e Nevis 3
LY - Libia 3
YE - Yemen 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BW - Botswana 2
Totale 16.740
Città #
Singapore 774
Southend 737
Ashburn 475
Fairfield 438
Chandler 335
Dublin 319
Princeton 290
Council Bluffs 269
Jakarta 241
Seattle 230
Woodbridge 227
Beijing 224
Milan 223
Houston 195
Wilmington 195
Hanover 156
Cambridge 148
Des Moines 121
Shanghai 120
Guangzhou 115
Frankfurt am Main 108
Bengaluru 106
Nuremberg 103
Ann Arbor 93
Taipei 87
Redwood City 86
Berlin 71
Nanjing 69
Santa Clara 67
Dong Ket 63
Seoul 63
Addis Ababa 59
Helsinki 58
Washington 55
Hong Kong 54
Boardman 53
New York 53
Tokyo 51
Hangzhou 50
Rome 46
San Diego 46
Brisbane 45
Dhaka 43
Silver Spring 43
Melbourne 42
London 38
Los Angeles 38
Vienna 38
Bangkok 36
Paris 35
Madrid 32
Shenyang 32
Wuhan 32
Jinan 31
Slough 31
Tehran 30
Zhengzhou 29
Chicago 28
São Paulo 28
The Dalles 28
Changsha 27
Chengdu 27
Phoenix 26
Rho 26
Boston 25
Columbus 25
Montreal 25
Port Harcourt 25
Chongqing 24
Fuzhou 24
Lappeenranta 24
Upper Marlboro 23
Amsterdam 22
Nanchang 22
Toronto 22
Bühl 21
Dearborn 21
Kuala Lumpur 21
Piscataway 20
Sydney 20
Auckland 19
Barcelona 19
Central 19
Hyderabad 19
Kathmandu 19
Manila 19
Osaka 19
Santiago 19
Cape Town 18
Moscow 18
Istanbul 17
Mumbai 17
Oxford 17
San Jose 17
Atlanta 16
Hamburg 16
Central District 15
Dallas 15
Edinburgh 15
Jerusalem 15
Totale 8.750
Nome #
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 903
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017. A Systematic Analysis for the Global Burden of Disease Study 815
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 622
Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 477
Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections 324
Platelet-Rich Plasma for Wound Healing 282
Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond 276
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 248
Risk of COVID-19 Infection, Hospitalization, and Mortality in Patients with Psoriasis Treated by Interleukin-17 Inhibitors 234
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. 227
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 192
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018 186
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa : a multi-center retrospective analysis 178
Low Prevalence of GSC Gene Mutations in a Large Cohort of Predominantly Caucasian Patients with Hidradenitis Suppurativa 177
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 174
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 173
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 170
The impact of intermittent fasting (Ramadan fasting) on psoriatic arthritis disease activity, enthesitis, and dactylitis: A multicentre study 169
Fasting and Its Impact on Skin Anatomy, Physiology, and Physiopathology: A Comprehensive Review of the Literature 158
Suspected eosinophilic pustular folliculitis presenting as rapidly evolving acneiform eruption 155
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new direct-acting antiviral agents 154
Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019 151
A comprehensive systematic review of leishmaniasis in patients undergoing drug-induced immunosuppression for the treatment of dermatological, rheumatological and gastroenterological diseases 150
Italian expert consensus on clinical and therapeutic management of multiple chemical sensitivity (Mcs) 142
Mapping routine measles vaccination in low- and middle-income countries 136
The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study 130
Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis) 129
When IL-17 inhibitors fail : real-life evidence to switch from secukinumab to adalimumab or ustekinumab 128
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021 127
Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017 126
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 126
The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone 123
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 122
Liver Illness and Psoriatic Patients 120
Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review 119
Effectiveness of community face mask use on COVID-19 epidemiological trends and patterns in Italy : evidence from a “translational” study 116
Principles of wound dressings : A review 114
Sleep quality in parents with children affected by psoriasis, psoriatic arthritis or atopic dermatitis: a multicenter cross-sectional study 112
Severe bitter taste associated with apremilast 111
Increased Risk of Pemphigus among Patients with Psoriasis: A Large-scale Cohort Study 111
Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms 107
Current and future targeted therapies for severe asthma : managing treatment with biologics based on phenotypes and biomarkers 106
Nanotechnology meets atopic dermatitis : current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature 106
Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning 106
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review 105
COVID-19 knowledge prevents biologics discontinuation : Data from an Italian multicenter survey during RED-ZONE declaration 104
Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase™) 103
Gut microbiota and nutrient interactions with skin in psoriasis : a comprehensive review of animal and human studies 102
Exhaled nitric oxide as a biomarker in COPD and related comorbidities 101
Mobile teledermatology for melanoma detection : assessment of the validity in the framework of a population-based skin cancer awareness campaign in northern Italy 101
Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: Analysis for the Global Burden of Disease Study 2017 101
COVID‐19 related masks increase severity of both acne (Maskne) and rosacea (Mask rosacea): Multi‐center, real‐life, telemedical, observational prospective study 101
The prevalence of onchocerciasis in Africa and Yemen, 2000–2018: a geospatial analysis 100
Differences in osteoimmunological biomarkers predictive of psoriatic arthritis among a large Italian cohort of psoriatic patients 98
How big data and artificial intelligence can help better manage the covid-19 pandemic 96
Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation 96
Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 94
Mapping development and health effects of cooking with solid fuels in low-income and middle-income countries, 2000–18: a geospatial modelling study 93
Female Patients with Dermatitis Herpetiformis Show a Reduced Diagnostic Delay and Have Higher Sensitivity Rates at Autoantibody Testing for Celiac Disease 92
Use of an Artificial Neural Network to Identify Patient Clusters in a Large Cohort of Patients with Melanoma by Simultaneous Analysis of Costs and Clinical Characteristics 91
Mask‐Induced Koebner phenomenon and its clinical phenotypes: a multicenter, real‐life study focusing on 873 dermatological consultations during COVID ‐19 pandemics 90
Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting real-world data from a multicenter observational study targeting inflammatory and infectious dermatoses 86
The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study 86
Patient‐reported outcomes of topical therapies in actinic keratosis : a systematic review 83
Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study 83
A mysterious abdominal pain during active psoriasis 81
Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study 81
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 80
Is pyoderma gangrenosum associated with solid malignancies? Insights from a population‐based cohort study 80
Hidradenitis suppurativa in Black and White patients - a clinical study 78
Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study 78
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 77
Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics : Aprepitant Vs Antihistamine double dosage, a real-world data 75
The Bidirectional Association Between Bullous Pemphigoid and Psoriasis : a Population-Based Cohort Study 74
The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? 74
Autoinflammatory disease damage index (ADDI) : a possible newborn also in hidradenitis suppurativa daily practice 72
SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights 72
A unique pneumopathy in a patient with skin nodules and abscesses 71
Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration 71
Possible new inflammatory side-effect of SGLT2-inhibitors : fixed drug eruption 69
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic : an Italian experience 69
Interaction of Resistin and Systolic Blood Pressure in Psoriasis Severity 67
Malar rash is a predictor of subclinical airway inflammation in patients with systemic lupus erythematosus : a pilot study 66
Dietary compounds as potential modulators of microRNA expression in psoriasis 66
Psoriasis and Psoriatic Arthritis Cardiovascular Disease Endotypes Identified by Red Blood Cell Distribution Width and Mean Platelet Volume 66
Dysthyroidism in dermato/polymyositis patients : a case-control study 66
Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population 65
Sleep quality in partners with spouses and children affected by psoriasis and psoriatic arthritis: insights and implications from a pilot study 64
Use of fumaric acid derivatives (FADs) in Italian reference centres for psoriasis 64
The overlapping burden of the three leading causes of disability and death in sub-Saharan African children 63
An adalimumab-induced late-onset immune reconstitution inflammatory syndrome treated with adalimumab 63
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 63
Dermoscopy of the Month 63
Molecular Proof of a Clinical Concept: Expression of Estrogen Alpha-, Beta-Receptors and G Protein-Coupled Estrogen Receptor 1 (GPER) in Histologically Assessed Common Nevi, Dysplastic Nevi and Melanomas 63
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 62
Patients with pemphigus are at an increased risk of developing rheumatoid arthritis : a large-scale cohort study 60
Geographic tongue clinical response in moderate-to-severe psoriatic patients undergoing secukinumab: a real-life, multicenter retrospective observational study 60
The use of PRISM (Pictorial Representation of Illness and Self Measure) in patients affected by chronic cutaneous ulcers 59
The burden of skin and subcutaneous diseases in the United States from 1990 to 2017 59
Diet-related phototoxic reactions in psoriatic patients undergoing phototherapy : Results from a multicenter prospective study 59
Totale 13.518
Categoria #
all - tutte 68.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020158 0 0 0 0 0 0 0 0 0 83 40 35
2020/20212.776 86 81 86 116 505 244 288 297 196 301 194 382
2021/20222.952 235 252 303 183 263 336 191 188 219 194 173 415
2022/20232.368 295 176 254 189 173 373 103 114 194 111 262 124
2023/20242.904 140 150 162 226 414 341 191 177 103 209 314 477
2024/20255.944 297 649 224 676 544 740 618 827 1.346 23 0 0
Totale 17.861